← brief for 2026-10-17 · Slowing decline

Real-World Renal Effects of Dapagliflozin in Bulgarian Patients with Chronic Kidney Disease of Predominantly Glomerular Origin: A Two-Year Comparative Cohort Study with Historical Controls

Article C Peer reviewed Observational

Key takeaways

This study compared 147 patients taking dapagliflozin with 170 past records. It looked at kidney function and protein in the urine over two years. The group on the drug had better outcomes. This is an observational study, so it shows a link, not proof of cause.

Who did this work

Veronica Aladzhova (Queen Giovanna Hospital) · Teodora Ilieva (Queen Giovanna Hospital) · Bilyana Vasileva (Queen Giovanna Hospital) · Mariana Petkova (Queen Giovanna Hospital) · Martin Milkinski (Queen Giovanna Hospital) · Simona Kuzmanova-Hrischeva (Queen Giovanna Hospital) · Simona Kerezieva (Queen Giovanna Hospital) · Ina Georgieva (Alexandrovska Hospital) · I. Trendafilov (Alexandrovska Hospital) · Maria Atanasova Radanova (Medical University of Varna) · Vasil V. Vasilev (Queen Giovanna Hospital)

Source

Article · OpenAlex, CKD works · 2026-10-16
https://doi.org/10.3390/biomedicines14102353